Elite in Factor 10 Deficiency

Kaan Kavakli

Ege, TR 
Elite in Factor 10 Deficiency
Ege, TR 
OverviewLocationsClinical Research

Overview

Kaan Kavakli practices in Ege, Turkey. Mr. Kavakli is rated as an Elite expert by MediFind in the treatment of Factor 10 Deficiency. His top areas of expertise are Factor 10 Deficiency, Blood Clots, Hemophilia A, Hemophilia B, and Synovectomy.

His clinical research consists of co-authoring 100 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 7 articles in the study of Factor 10 Deficiency.

Gender
Male

Locations

Ege, Turkey
Other Locations
Bornova, Turkey
Izmir, Turkey

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Phase 3, Prospective, Multi-center, Open Label Study to Investigate Safety, Immunogenicity and Hemostatic Efficacy of PEGylated Factor VIII (BAX 855) in Previously Untreated Patients (PUPs) < 6 Years With Severe Hemophilia A (FVIII < 1%)
Phase 3, Prospective, Multi-center, Open Label Study to Investigate Safety, Immunogenicity and Hemostatic Efficacy of PEGylated Factor VIII (BAX 855) in Previously Untreated Patients (PUPs) < 6 Years With Severe Hemophilia A (FVIII < 1%)
Enrollment Status: Completed
Publish Date: July 28, 2025
Intervention Type: Biological
Study Drugs: PEG-Factor VIII, Eloctate ITI
Study Phase: Phase 3
Natural History Study of Factor IX Treatment and Complications
Natural History Study of Factor IX Treatment and Complications
Enrollment Status: Unknown
Publish Date: May 25, 2021
Intervention Type: Other
View 1 Less Clinical Trial

100 Total Publications

Health-related quality of life in adults with hemophilia B after gene therapy with fidanacogene elaparvovec: Results from the BENEGENE-2 trial.
Health-related quality of life in adults with hemophilia B after gene therapy with fidanacogene elaparvovec: Results from the BENEGENE-2 trial.
Journal: Journal of thrombosis and haemostasis : JTH
Published: April 17, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Kavakli's expertise for a condition
ConditionClose
View All 21 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile